J&J uses web video, teacher outreach in UK ADHD effort

Share this article:
J&J uses web video, teacher outreach in UK ADHD effort
J&J uses web video, teacher outreach in UK ADHD effort

Johnson & Johnson's Janssen-Cilag launched an animated patient education video aimed at showing viewers the world from the perspective of a child with ADHD and urging parents to see a doctor about behavioral problems.

The film is part of an unbranded UK campaign including outreach to teachers and is featured on Livingwithadhd.co.uk. The film employs a technique called “rotoscoping,” in which real actors are filmed and converted into animations, and was developed through interviews with patients, parents, doctors and teachers. It visually depicts the child's attention drifting and explores the guilt that parents of children with ADHD often feel.

It's meant encourage parents to take the initial step of seeing a doctor about their child's behavioral problems – a step that research shows gives parents great satisfaction, the company said, either for relief that a diagnosis has been made or for reassurance at having spoken to a professional.

“It might be that certain teachers currently have children with ADHD in their classrooms but that haven't yet realized it or are struggling to cope,” said ADHD educational advisor Holly Evans in a release. “If improved understanding and knowledge about ADHD can filter down to at least a small proporation of the teaching population, it will make a big impact.”

The J&J unit makes Concerta XL for ADHD.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.